Start Date
May 31, 2019
Primary Completion Date
December 31, 2020
Study Completion Date
February 28, 2021
Immunoscore Colon Test
Immunoscore Colon is a CE-marked in-vitro diagnostic test, allowing the quantification of CD3 and CD8 positive cells in formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colon cancer. The test uses immunohistochemistry, digital pathology techniques and a dedicated software.
Hôpital Européen Marseille, Marseille
Hôpital Simone Veil, Blois
Hospices civils de Colmar, Colmar
CHU de Dijon, Dijon
CHD de Vendée, La Roche-sur-Yon
Centre Oscar Lambret, Lille
CHU de Limoges, Limoges
Centre Léon Bérard, Lyon
Hôpital Jean Mermoz, Lyon
Institut Régional du Cancer de Montpellier, Montpellier
CHU Hôtel-Dieu, Nantes
Hôpital Saint-Louis, Paris
CHU de Bordeaux - Haut Lévêque, Pessac
CHU de Poitiers, Poitiers
Centre Hospitalier Annecy Genevois, Pringy
CHU de Reims, Reims
Centre Eugène Marquis, Rennes
Institut de Cancérologie de l'Ouest, Saint-Herblain
Hôpital du Léman, Thonon-les-Bains
Institut Gustave Roussy, Villejuif
Hôpital privé de Villeneuve d'Ascq, Villeneuve-d'Ascq
Collaborators (1)
HalioDx
INDUSTRY
UNICANCER
OTHER